Bio

Wonpyo rejoined Aisling in 2022 as a Principal, having previously served as an Analyst from 2016 to 2019. Most recently, Wonpyo was an Investment Director at BridgeBio, where he focused on investing and business development activities. He began his career at Credit Suisse in the Healthcare Investment Banking Group. Wonpyo received his M.B.A. from the Stanford Graduate School of Business and his A.B. in Molecular Biology, awarded magna cum laude, from Princeton University, from which he also received a Certificate in Finance.